Answers from the Lab

John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides cost-effective testing to determine the antigen that's causing the kidney disease.

Show Notes

(00:31) 
 Could you tell us a bit about yourself and your background?

(01:11)
 Could you describe these new tests and when it would be appropriate to use each of them in the clinic?

(03:16)
 Could you provide a little background on why MCL is making changes to the PLA2R test?

(04:34)
 Could you describe the change to KDIGO guidelines and when it may be appropriate to skip the biopsy? How will these new tests help physicians implement these new guidelines in their practices?

What is Answers from the Lab?

A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.